Skip to search formSkip to main contentSkip to account menu

RNF43 gene

Known as: RNF124, RNF43, DKFZp781H0392 
This gene is involved in both protein ubiquitination and the Wnt signaling pathway.
National Institutes of Health

Related topics

Related topics

4 relations
RNF8 geneSignal Transduction InhibitionUbiquitinated Protein DegradationUbiquitination

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
The safety and immunological responsiveness of a peptide vaccine of ring finger protein 43 and 34-kDa translocase of the outer… 
2017
2017
RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers
The WNT signaling pathway is commonly altered during colorectal cancer development. The E3 ubiquitin ligase, RNF43, negatively… 
2017
2017
RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer
Comprehensive genetic analysis of colorectal malignant tumors by microarrays has identified translocase of the outer… 
2015
2015
EXCAP exercise effects on cognitive impairment and inflammation: A URCC NCORP RCT in 479 cancer patients.
9504 Background: Cognitive impairment (CI) is one of the most troublesome side effects experienced by patients, arises due to… 
2015
2015
Abstract C45: Phase I study of WNT974, a first-in-class Porcupine inhibitor, in advanced solid tumors
Background: Aberrant Wnt pathway activation is critical for initiation and maintenance of multiple tumor types, yet therapeutic… 
2014
2014
Unclassified renal cell carcinoma: a clinicopathological, comparative genomic hybridization, and whole-genome exon sequencing study.
Unclassified renal cell carcinoma (URCC) is a rare variant of RCC, accounting for only 3-5% of all cases. Studies on the… 
2012
2012
[Clinical study of Peptide-cocktail vaccination with tegafur-uracil/leucovorin for advanced colorectal cancer].
cDNA microarray technology coupled with laser microdissection has been used to identify human leukocyte antigen(HLA)-A24… 
2011
2011
Racial disparities in traumatic stress in prostate cancer patients: secondary analysis of a National URCC CCOP Study of 317 men
IntroductionAfrican American men have the highest rates of prostate cancer of any racial group, but very little is known about… 
2009
2009
Metronomic schedule of paclitaxel is effective in hormone receptor-positive and hormone receptor-negative breast cancer.
2006
2006
Self-reported cognitive impairment in cancer patients: A URCC CCOP longitudinal study of 595 patients.
8502 Background: Patients undergoing cancer treatment often report cognitive impairment, manifested as problems with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)